|
Status |
Public on Jun 05, 2009 |
Title |
DU145_preNeg_rep3 |
Sample type |
RNA |
|
|
Source name |
negative control
|
Organism |
Homo sapiens |
Characteristics |
DU145 cells transfected with Pre-miR™ miRNA Precursor Molecule negative control #1(Ambion)
|
Treatment protocol |
Transfection with 20nM Pre-miR™ miRNA Precursor Molecules (Ambion), using Lipofectamine2000 (Invitrogen).
|
Extracted molecule |
total RNA |
Extraction protocol |
Three days after transfection, cells were harvested and total RNA extracted using Trizol Reagent (Invitrogen) according to the manufacturer's instructions
|
Label |
Cy3
|
Label protocol |
standard Illumina protocol (Cy3)
|
|
|
Hybridization protocol |
standard Illumina protocol
|
Scan protocol |
standard Illumina protocol
|
Description |
DU145 cells transfected with Pre-miR™ miRNA Precursor Molecule negative control #1(Ambion)
|
Data processing |
BeadStudio Gene Expression Module v_3; cubic spline normalization; filtering: detection p-value<0.05
|
|
|
Submission date |
Jun 06, 2008 |
Last update date |
Jun 06, 2008 |
Contact name |
Paolo Gandellini |
E-mail(s) |
[email protected]
|
Organization name |
Fondazione IRCCS Istituto Nazionale Tumori
|
Department |
Department of Applied Research and Technological Development
|
Street address |
Via Amadeo 42
|
City |
Milan |
ZIP/Postal code |
20133 |
Country |
Italy |
|
|
Platform ID |
GPL6104 |
Series (1) |
GSE11701 |
Genes modulated by miR-205 in DU145 prostate cancer cells |
|